Clinical Trials Sponsored by Asmacure Ltée

Total 8 results

Asmacure Ltée

Completed

Safety, Tolerability and Clinical Activity of ASM-024 in Stable Moderate Asthma

Asthma

Canada
Asmacure Ltée

Terminated

Safety, Tolerability and Pharmacokinetics of ASM-024 Administered to Healthy Subjects and Subjects With Moderate Asthma

Asthma

Canada
Asmacure Ltée

Completed

Safety, Tolerability, and Clinical Activity of ASM-024 Administered to Patients With GOLD 2 or GOLD 3 Chronic Obstructive Pulmonary Disease (COPD)

COPD

Canada
Asmacure Ltée

Completed

Safety, Tolerability and Clinical Activity of ASM-024 in Subjects With Mild Allergic Asthma

Mild Allergic Asthma

Canada
amcure GmbH

Completed

A Safety and Pharmacokinetic Phase I/Ib Study of AMC303 in Patients With Solid Tumours

Malignant Solid Tumor

Belgium, Spain
Plasmacure
European Commission

Terminated

PLASOMA Efficacy & Technology Health (PETH) Study

Venous Leg Ulcer

Netherlands
Plasmacure
Diabetes Fonds; Pathology and Medical Microbiology

Active, not recruiting

PLASOMA Ultimate Safety & Efficacy Study (PULSE)

Diabetic Foot Ulcer | Venous Leg Ulcer | Burn Wound | Pressure Ulcer | Skin Graft | Infected Surgical Wound | Skin Flap

Netherlands
University College Cork
University of Southampton; Carol Davila University of Medicine and Pharmacy; Engineering... and other collaborators

Not yet recruiting

Environmental Influence on Mental Illness Via Modifications of Genomes and Metabolomes in Adolescents With Autism (ENIGMA-I)

Autism Spectrum Disorder | Autism

Ireland, United Kingdom, Romania

Clinical Trials Sponsored by Asmacure Ltée

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations